Halozyme Therapeutics, Inc.

VOLORIDGE INVESTMENT MANAGEMENT, LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

754,514

Value ($000)

50,779

Weight

0.2%

2019 Q4 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	50,779	0.2%	754,514	12/31/2025
2025 Q3	11/14/2025	77,587	0.3%	1,057,902	9/30/2025
2024 Q4	2/14/2025	876	0.0%	18,321	12/31/2024
2024 Q2	8/14/2024	4,195	0.0%	80,110	6/30/2024
2024 Q1	5/15/2024	16,203	0.1%	398,306	3/31/2024
2023 Q4	2/14/2024	2,023	0.0%	54,734	12/31/2023
2022 Q4	2/14/2023	12,067	0.1%	212,076	12/31/2022
2022 Q3	11/14/2022	2,816	0.0%	71,229	9/30/2022
2022 Q2	8/15/2022	16,197	0.1%	368,123	6/30/2022
2022 Q1	5/16/2022	5,696	0.0%	142,836	3/31/2022
2021 Q4	2/14/2022	10,285	0.1%	255,786	12/31/2021
2021 Q3	11/15/2021	4,630	0.0%	113,825	9/30/2021
2020 Q4	2/16/2021	8,719	0.1%	204,136	12/31/2020
2020 Q3	11/16/2020	9,812	0.1%	373,373	9/30/2020
2020 Q2	8/14/2020	7,914	0.1%	295,173	6/30/2020
2019 Q4	2/14/2020	1,758	0.0%	99,168	12/31/2019